ASTH
Astrana Health, Inc.
-0.62 (-1.63%)37.09USD391K成交股數2.1B市值45.2本益比(近四季)0.5股價營收比+48.5%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 973M+57% | 965M+45% | 956M+100% | 655M+35% | 620M+53% | 665M+91% | 479M+37% | 486M+44% | 404M | 348M | 348M | 337M |
| 營業成本 | 868M | 859M | 859M | 577M | 549M | 615M | 405M | 413M | 330M | 275M | 293M | 289M |
| 毛利 | 104M+46% | 106M+109% | 97.2M+32% | 78.0M+6% | 71.3M-4% | 50.5M-31% | 73.5M+33% | 73.5M+54% | 74.0M | 72.8M | 55.3M | 47.8M |
| 毛利率 | 10.7% | 11.0% | 10.2% | 11.9% | 11.5% | 7.6% | 15.4% | 15.1% | 18.3% | 20.9% | 15.9% | 14.2% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 54.2M | 61.7M | 62.4M | 50.7M | 43.9M | 41.6M | 37.8M | 36.0M | 38.7M | 29.4M | 24.1M | 21.2M |
| 營業利益 | 34.3M+67% | 28.5M+3862% | 19.2M-32% | 20.3M-32% | 20.6M-32% | 720K-98% | 28.4M+5% | 30.1M+34% | 30.1M | 39.1M | 27.0M | 22.4M |
| 營業利益率 | 3.5% | 3.0% | 2.0% | 3.1% | 3.3% | 0.1% | 5.9% | 6.2% | 7.5% | 11.2% | 7.8% | 6.6% |
| 稅後淨利 | 19.7M+195% | 14.4M-14536% | 373K-98% | 9.4M-51% | 6.7M-55% | −100K-100% | 16.1M+22% | 19.2M+46% | 14.8M | 22.1M | 13.2M | 13.1M |
| 淨利率 | 2.0% | 1.5% | 0.0% | 1.4% | 1.1% | -0.0% | 3.4% | 3.9% | 3.7% | 6.3% | 3.8% | 3.9% |
| 稀釋 EPS | 0.40+186% | 0.29-307% | 0.01-97% | 0.19-53% | 0.14-55% | -0.14-130% | 0.33+18% | 0.40+43% | 0.31 | 0.47 | 0.28 | 0.28 |
| 稀釋股數 | 49.8M | 49.1M | 49.5M | 49.5M | 48.9M | 48.0M | 48.2M | 48.0M | 47.7M | 46.9M | 46.8M | 47.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 401M | 478M | 462M | 340M | 259M | 288M | 348M | 325M | 335M | 274M | 294M | 275M |
| 應收帳款 | 465M | 467M | 381M | 349M | – | 276M | – | – | – | – | – | 76.0M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 2.3B | 2.4B | 2.2B | 1.4B | 1.3B | 1.4B | 1.3B | 1.3B | 1.2B | 1.1B | 1.0B | 999M |
| 有息負債 | 883M | 980M | 1.0B | 401M | 404M | 425M | 423M | 425M | 368M | 206M | 205M | 205M |
| 總負債 | 1.7B | 1.8B | 1.7B | 904M | 814M | 841M | 778M | 774M | 774M | 458M | 444M | 434M |
| 股東權益 | 830M | 800M | 776M | 765M | 745M | 713M | 705M | 679M | 653M | 594M | 566M | 548M |
| 負債比 | 73.8% | 75.5% | 75.2% | 62.7% | 61.1% | 62.1% | 60.5% | 61.8% | 63.1% | 42.6% | 43.2% | 43.4% |
| 淨現金(現金 − 有息負債) | −482M | −501M | −540M | −61.4M | −145M | −137M | −75.1M | −99.7M | −33.7M | 67.7M | 88.8M | 69.7M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 68.1M | – | – | 16.6M+178% | – | – | – | 6.0M | – | – | 7.7M |
| 資本支出 | – | 4.0M | – | – | 3.1M | – | – | – | 369K | – | – | 6.0M |
| 自由現金流 | – | 64.1M | – | – | 13.6M+142% | – | – | – | 5.6M | – | – | 1.7M |
| 折舊攤銷 | – | 15.5M | – | – | 6.8M | – | – | – | 5.1M | – | – | 4.3M |
| 買回庫藏股 | – | 2.8M | – | – | 10.6M | – | – | – | – | – | – | 0.00 |
| 現金股利 | – | 104K | – | – | 5.5M | – | – | – | 95K | – | – | 120K |
| 自由現金流率 | – | 6.6% | – | – | 2.2% | – | – | – | 1.4% | – | – | 0.5% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.5B
| Care Partners | 3.0B | 85.9% | +55.1% |
|---|---|---|---|
| Care Delivery | 251M | 7.1% | +83.5% |
| Care Enablement | 247M | 7.0% | +58.7% |
主要客戶2025 年度 · 3.2B
| Medicare | 1.9B | 59.9% | +58.9% |
|---|---|---|---|
| Medicaid | 861M | 27.1% | +49.3% |
| Commercial | 276M | 8.7% | +51.6% |
| Other Third Parties | 138M | 4.3% | +81.5% |
產品／服務2025 年度 · 3.2B
| Health Care Capitation Revenue | 2.9B | 91.9% | +57.5% |
|---|---|---|---|
| Health Care Patient Service | 113M | 3.5% | +80.7% |
| Health Care Other | 86.2M | 2.7% | 0.0% |
| Management Service | 30.4M | 1.0% | +117.4% |
| Product And Service Other | 28.3M | 0.9% | +85.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.2B | +56.4% | 24.0M | 0.8% | 0.46 | 104M |
| FY2024 | 2.0B | +46.7% | 50.0M | 2.5% | 0.90 | 44.2M |
| FY2023 | 1.4B | +21.2% | 58.0M | 4.2% | 1.29 | 39.7M |
| FY2022 | 1.1B | +47.8% | 46.0M | 4.0% | 0.99 | 59.2M |
| FY2021 | 774M | +12.6% | 46.0M | 5.9% | 1.52 | 51.1M |
| FY2020 | 687M | +22.6% | 37.7M | 5.5% | 1.01 | 45.0M |
| FY2019 | 561M | +7.8% | 14.1M | 2.5% | 0.39 | 12.6M |
| FY2018 | 520M | – | 10.8M | 2.1% | 0.29 | 24.3M |